Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Marta C. Nunes, Marta Moreira, Anthonet Koen, Nadia van Niekerk, Lisa Jose, Clare L. Cutland, Nancy François, Sonia Schoonbroodt, Javier Ruiz-Guiñazú, Juan Pablo Yarzabal, Dorota Borys, Lode Schuerman & Shabir A. Madhi. (2020) Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert Review of Vaccines 19:12, pages 1177-1189.
Read now
Read now
Nicola Principi & Susanna Esposito. (2018) Development of pneumococcal vaccines over the last 10 years. Expert Opinion on Biological Therapy 18:1, pages 7-17.
Read now
Read now
Nicola Principi, Valentina Preti, Stefania Gaspari, Antonella Colombini, Marco Zecca, Leonardo Terranova, Maria Giuseppina Cefalo, Valentina Ierardi, Claudio Pelucchi & Susanna Esposito. (2016) Streptococcus pneumoniae pharyngeal colonization in school-age children and adolescents with cancer. Human Vaccines & Immunotherapeutics 12:2, pages 301-307.
Read now
Read now
Articles from other publishers (8)
Anand Kawade, Girish Dayma, Aditi Apte, Nilima Telang, Meenakshi Satpute, Emma Pearce, Lucy Roalfe, Rakesh Patil, Yanyun Wang, Navideh Noori, Arun Gondhali, Sanjay Juvekar, Assaf P. Oron, Sonali Sanghavi, David Goldblatt, Ron Dagan & Ashish Bavdekar. (2023) Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children. Vaccine 41:19, pages 3066-3079.
Crossref
Crossref
Naoko Fuji, Michael Pichichero & Ravinder Kaur. (2022) Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model. Vaccine 40:44, pages 6412-6421.
Crossref
Crossref
R.K. Lucinde, G. Ong'ayo, C. Houlihan, C. Bottomley, D Goldblatt, J.A.G. Scott & K.E. Gallagher. (2021) Pneumococcal conjugate vaccine dose-ranging studies in humans: A systematic review. Vaccine 39:36, pages 5095-5105.
Crossref
Crossref
Ravinder Kaur, Minh Pham & Michael Pichichero. (2021) Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children. Vaccine 39:29, pages 3900-3906.
Crossref
Crossref
Wondewosen Tsegaye Sime, Abraham Aseffa, Yimtubezenash Woldeamanuel, Sarah Brovall, Eva Morfeldt & Birgitta Henriques-Normark. (2019) Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia. BMC Infectious Diseases 19:1.
Crossref
Crossref
John M. McLaughlin, Qin Jiang, Bradford D. Gessner, David L. Swerdlow, Heather L. Sings, Raul E. Isturiz & Luis Jodar. (2019) Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis. Vaccine 37:43, pages 6310-6316.
Crossref
Crossref
John Ojal, Laura L. Hammitt, John Gaitho, J. Anthony G. Scott & David Goldblatt. (2017) Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage. Vaccine 35:35, pages 4652-4657.
Crossref
Crossref
Cornelius Remschmidt, Thomas Harder, Ole Wichmann, Christian Bogdan & Gerhard Falkenhorst. (2016) Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review. BMC Infectious Diseases 16:1.
Crossref
Crossref